These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15893843)

  • 1. VEGF-induced angiogenesis drives collateral circulation in portal hypertension.
    Moreau R
    J Hepatol; 2005 Jul; 43(1):6-8. PubMed ID: 15893843
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of VEGF receptor-2 decreases the development of hyperdynamic splanchnic circulation and portal-systemic collateral vessels in portal hypertensive rats.
    Fernandez M; Mejias M; Angermayr B; Garcia-Pagan JC; Rodés J; Bosch J
    J Hepatol; 2005 Jul; 43(1):98-103. PubMed ID: 15893841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic changes in splanchnic blood vessels in portal hypertension.
    Colle I; Geerts AM; Van Steenkiste C; Van Vlierberghe H
    Anat Rec (Hoboken); 2008 Jun; 291(6):699-713. PubMed ID: 18484617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased angiogenesis and permeability in the mesenteric microvasculature of rats with cirrhosis and portal hypertension: an in vivo study.
    Geerts AM; De Vriese AS; Vanheule E; Van Vlierberghe H; Mortier S; Cheung KJ; Demetter P; Lameire N; De Vos M; Colle I
    Liver Int; 2006 Sep; 26(7):889-98. PubMed ID: 16911473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-VEGF receptor-2 monoclonal antibody prevents portal-systemic collateral vessel formation in portal hypertensive mice.
    Fernandez M; Vizzutti F; Garcia-Pagan JC; Rodes J; Bosch J
    Gastroenterology; 2004 Mar; 126(3):886-94. PubMed ID: 14988842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Portal hypertension and angiogenesis].
    Stumm M; Sieber C
    Schweiz Med Wochenschr; 2000 Feb; 130(7):233-9. PubMed ID: 10719714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular deterioration in cirrhosis: the big picture.
    Bosch J
    J Clin Gastroenterol; 2007; 41 Suppl 3():S247-53. PubMed ID: 17975472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiogenesis in portal hypertension: involvement in increased splanchnic blood flow and collaterals?
    Geerts AM; Colle I
    Acta Clin Belg; 2007; 62(5):271-5. PubMed ID: 18229459
    [No Abstract]   [Full Text] [Related]  

  • 9. Portal-systemic collaterals and angiogenesis.
    Chan CC
    J Chin Med Assoc; 2009 May; 72(5):223-4. PubMed ID: 19467943
    [No Abstract]   [Full Text] [Related]  

  • 10. Nitric oxide and portal hypertension: interface of vasoreactivity and angiogenesis.
    Langer DA; Shah VH
    J Hepatol; 2006 Jan; 44(1):209-16. PubMed ID: 16297493
    [No Abstract]   [Full Text] [Related]  

  • 11. Molecular mechanisms of increased intrahepatic resistance in portal hypertension.
    Shah V
    J Clin Gastroenterol; 2007; 41 Suppl 3():S259-61. PubMed ID: 17975474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mild increases in portal pressure upregulate vascular endothelial growth factor and endothelial nitric oxide synthase in the intestinal microcirculatory bed, leading to a hyperdynamic state.
    Abraldes JG; Iwakiri Y; Loureiro-Silva M; Haq O; Sessa WC; Groszmann RJ
    Am J Physiol Gastrointest Liver Physiol; 2006 May; 290(5):G980-7. PubMed ID: 16603731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different vascular endothelial growth factor (VEGF), VEGF-receptor 1 and -2 mRNA expression profiles between clear cell and papillary renal cell carcinoma.
    Ljungberg BJ; Jacobsen J; Rudolfsson SH; Lindh G; Grankvist K; Rasmuson T
    BJU Int; 2006 Sep; 98(3):661-7. PubMed ID: 16925769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pro-angiogenic cytokines and their role in tumor angiogenesis.
    Neufeld G; Kessler O
    Cancer Metastasis Rev; 2006 Sep; 25(3):373-85. PubMed ID: 17006765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Portal hypertension and variceal hemorrhage.
    Toubia N; Sanyal AJ
    Med Clin North Am; 2008 May; 92(3):551-74, viii. PubMed ID: 18387376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Portal hypertension and blood viscosity.
    Sikuler E
    J Clin Gastroenterol; 2007; 41 Suppl 3():S262-5. PubMed ID: 17975475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A new view on angiogenesis and effect of dearterialization of the liver in the surgery of portal hypertension and oncohepatology].
    Kashchenko VA
    Vestn Khir Im I I Grek; 2003; 162(2):114-6. PubMed ID: 14606165
    [No Abstract]   [Full Text] [Related]  

  • 18. [Systemic hemodynamics and blood coagulation in portal hypertension. Pathophysiologic and therapeutic aspects].
    Kühn HA; Liehr H
    Med Klin; 1977 Oct; 72(42):1713-20. PubMed ID: 335205
    [No Abstract]   [Full Text] [Related]  

  • 19. Lymphangiogenesis and angiogenesis in conventional renal cell carcinoma: association with vascular endothelial growth factors A to D immunohistochemistry.
    Iwata T; Miyata Y; Kanda S; Nishikido M; Hayashi T; Sakai H; Kanetake H
    Urology; 2008 Apr; 71(4):749-54. PubMed ID: 18295862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor family of ligands and receptors: review.
    Otrock ZK; Makarem JA; Shamseddine AI
    Blood Cells Mol Dis; 2007; 38(3):258-68. PubMed ID: 17344076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.